Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1371 The role of Circulating Tumor Cells (CTCs) in
Predicting the Response of Primary (Neoadjuvant)
Chemotherapy and its Impact as a Prognostic Factor in
Early Breast Cancer









































 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2014
1372 Trimodality bladder-sparing approach versus radical cystectomy for invasive bladder cancer
 		Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2014
1373 Detection of CARD 15 Gene Variants in Inflammatory Bowel Diseases and Colorecal Cancer. Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2014
1374 Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2014
1375 Detection of CARD 15 Gene Variants in Inflammatory Bowel Diseases and Colorecal Cancer. Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2014
1376 Impact of pain management using the WHO analgesic ladder in children with cancer in South Egypt Cancer Institute, Assiut University Department of Anesthesia, Intensive care and Pain management Dr. Montaser Abdel-Fattah Mohamed Mustafa 2014
1377 Fms-Like Tyrosine Kinase 3 expression in Childhood
Acute lymphoblastic Leukemia at South Egypt Cancer
Institute, Assiut University, Egypt 		Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2014
1378 Cyclin D1 Amplification in Multiple Myeloma Is
Associated With Multidrug Resistance Expression 		Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2014
1379 Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2014
1380 p-Stat3 and bcr/abl gene expression in chronic myeloid leukemia and their relation to imatinib therapy. Department of Clinical Pathology Prof. Mohamed Rafat / Mohammed Ibrahim Khalaf 2014